Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5014854_CN14854_0